
	Where results make sense

Topic: Sotret

In the News (Fri 24 May 13)

EXECUTIVE POWER

Iran

ANALYSIS

Pakistan

Family compact

	Sotret Information, Side Effects, Interactions, Ingredients, Generics
		Sotret is used to treat severe acne that has not responded to oral or topical anti-infectives.
		Sotret is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
		Sotret may cause depression, psychosis and, rarely, thoughts of suicide, suicide attempts or suicide.
	www.drugs-web.com /drugs/s/sotret.htm (479 words)

	Ranbaxy Pharmaceuticals Inc. - Brand Products
		Sotret is an oral drug that is usually taken twice a day with food for 15 to 20 weeks.
		In September 2003, Sotret was introduced in a 30 mg strength capsule in addition to the existing 10 mg, 20 mg and 40 mg strengths.
		Since Sotret is recommended for dosing on a per mg/kg body weight scale, this new strength provides a convenient option for physicians to prescribe and patients to take Sotret, as recommended.
	www.ranbaxyusa.com /branded/brand_products.htm (709 words)

	RANBAXY : Newsroom -> Press Releases (Site not responding. Last check: 2007-10-03)
		Ranbaxy’s wholly owned subsidiary, Ranbaxy Pharmaceuticals Inc. (RPI) will market this product under the brand name Sotret™ that will provide dosing flexibility to physicians and complement the existing strengths (10, 20, and 40 mg) currently available in the market that are commercialized under the Ranbaxy label.
		Sotret™ is being promoted by the Ranbaxy Brand Products Division (B.P.D.), towards building a portfolio of products with brand names.
		Sotret™ is a pending trademark applications of Ranbaxy Laboratories Ltd.
	www.ranbaxy.com /newsroom/pressrelease_det.asp?sno=111 (492 words)

	Branded drug from Ranbaxy gets US nod - Sify.com (Site not responding. Last check: 2007-10-03)
		Sotret is the generic version of acne drug Isotretinoin and the original patent holder for this drug is Hoffman LaRoche Inc, under the brandname Accutane.
		Isotretinoin capsules are indicated for severe recalcitrant nodular acne and because of the adverse effects associated with its use, Isotretinoin is reserved for patients with severe nodule acne that are unresponsive to conventional therapy, including systemic antibiotics, according to the company.
		Sotret was launched by Ranbaxy in the US in March this year and is being promoted by the Ranbaxy Brand Products Division.
	sify.com /finance/equity/fullstory.php?id=13179742 (253 words)

	Sarah's Accutane Journal: Adventures with Lipbalm: Comment on August 2003 (Site not responding. Last check: 2007-10-03)
		Alot of people nowadays are taking generic forms of accutance (i.e Sotret, Amnesteen etc...) these drugs are required to give its patients the same outcome as the regular Accutane.
		sotret was my last hope, my derm made it sound so wonderful.like there was no doubt in his mind that i would get better, but i do have doubts.
		it got to be so bad that i stopped taking sotret for three days (without telling my doc, which i later had to confess and start over) and the fl heads cleared up.
	www.hayllar.com /cgi-bin/mt/mt-comments.cgi?entry_id=1070 (8233 words)

	inVentiv Health - Newsroom - Press Releases
		Isotretinoin is the active ingredient in Sotret and the only FDA approved treatment for severe recalcitrant nodular acne.
		Sotret is the only brand of isotretinoin to offer the unique dosage strength of a 30mg capsule in addition to the 10, 20 and 40mg strengths, increasing the dosing options available to prescribers and patients.
		Given Ventiv's vast experience in the dermatology area, working with Ranbaxy to grow Sotret is a perfect fit for our two companies.
	www.ventiv.com /health/newsroom/pressReleaseDetail.asp?y=2004&id=66 (475 words)

	Ranbaxy gets FDA approval to manufacture and market Isotretinoin (Site not responding. Last check: 2007-10-03)
		Ranbaxy Laboratories Limited announced that the company has received approval from the US Food and Drug Administration to manufacture and commercialize Isotretinoin capsules USP, 30 mg, representing a new dosage strength for Isotretinoin.
		The company's wholly owned subsidiary, Ranbaxy Pharmaceuticals Inc (RPI) will market this product under the brand name Sotret that will provide dosing flexibility to physicians and complement the existing strengths (10, 20, and 40 mg) currently available in the market that are commercialized under the Ranbaxy label.
		BPD has established a team of over 35 professional sales representatives who promote Sotret to prescribers of Isotretinoin.
	www.expresspharmapulse.com /print.php?article=136 (478 words)

	FDA considers extending accutane deadline - Boston.com
		Doctors and patients, along with wholesalers and pharmacies, are supposed to be registered and activated in the computerized iPledge system by March 1 if they want to sell, prescribe or take the acne drug isotretinoin.
		Isotretinoin is sold as Accutane and in three generic versions: Amnesteem, Claravis and Sotret.
		But glitches in the program, as well as the slow progress in registering patients and others, have led to calls for a delay by the American Academy of Dermatology Association and others.
	www.boston.com /yourlife/health/children/articles/2006/02/10/fda_considers_extending_accutane_deadline (421 words)

	Mandatory registry opens for users of anti-acne drug \| Arizona Daily Star ®
		Doctors, wholesalers and pharmacies had until Friday to register with the computerized "iPledge" registry in order to continue prescribing or selling Accutane and any of the three generic versions of the drug, known as isotretinoin.
		Generic versions are sold as Amnesteem, Claravis or Sotret.
		The Food and Drug Administration has tried for more than 20 years to limit the exposure of fetuses to the drug, prescribed to about 100,000 Americans a month.
	www.azstarnet.com /sn/printDS/109382 (476 words)

	Sotret side effects (Site not responding. Last check: 2007-10-03)
		Get a personalized report about Sotret safety for yourself (or someone you love).
		It takes just minutes to learn what you need to know about Sotret: whether you are on a safe dose and what other hazards may exist like interactions, conflicts with other diseases you may have, duplication of therapy, reproductive hazards...all customized for you.
		Some other popular drug information and interaction topics this week have included: Nytol Caplet side effects as well as Levsin side effects, Sudafed Child Nasal Decongestant side effects, Inderal LA side effects and Naprelan 375 side effects.
	www.medicationadvisor.com /side_effects/Sotret.htm (2831 words)

	sotret - Acne.org Message Boards
		About a week ago I was clear, and now I am on Sotret and I am breaking out really bad.
		Now I am on Sotret and I'm wondering if this has different effects.
		Sotret is cleaning your face just like you clean a really messy room.
	www.acne.org /messageboard/index.php?showtopic=48730 (223 words)

	Slone Epidemiology Center - Study Information
		Isotretinoin is a drug uniquely effective for the treatment of severe acne; however, it is also a potent human teratogen.
		Isotretinoin is marketed as Accutane by its innovator and as Amnesteem, Claravis, and Sotret by three manufacturers of generic products.
		To minimize the risk of pregnancy during isotretinon treatment, the manufacturers, with guidance from FDA, instituted a mandatory, multi-component risk management program directed at physicians and patients.
	www.bu.edu /slone/Research/Studies/Accutane-Iso/ISO.htm (210 words)

	Ranbaxy gets FDA nod for Isotretinoin capsules
		Ranbaxy Laboratories on Monday said it has received the US Food and Drug Administration's approval to manufacture and market Isotretinoin capsules, a generic version of Hoffman LaRoche's Accutane.
		The company, which is the first to receive FDA for the Isotretinoin capsules of 30 mg, will market it under the name 'Sotret' by its subsidiary Ranbaxy Pharmaceuticals Inc.
		The capsules are indicated for recalcitrant nodular acne and the overall sales of the drug stood at $415 million, a company release said in New Delhi.
	www.rediff.com /money/2003/jun/23ranbaxy.htm (103 words)

	RANBAXY'S SOTRET ON SLOW WICKET IN US (Site not responding. Last check: 2007-10-03)
		Sotret, Ranbaxy’s first branded drug in the US market, cornered less than 1% of doctors’ prescriptions about a month after its launch.
		Sotret was the second off-patent version of Swiss drug-maker Roche’s blockbuster anti-acne drug isotretinoin to be launched in the US, the first being Amnesteem, a branded generic from American company Mylan that hit the market in November 2002.
		Brokerage CLSA Emerging Markets compared the performance of Mylan’s product in the first four weeks of its launch with Ranbaxy’s and concluded that the latter’s “ramp-up” has been slower due to the absence of a strong branded franchise.
	www.fdanews.com /dailies/world/1_58/news/12834-1.html (108 words)

	Sotret (accutane) - PCOS Message Board
		I am currently taking Sotret (a new generic for Accutane).
		So far, my skin has cleared up completely, but I have only been on it for about a month and I have to stay on it for at least 4 1/2 months total.
		I am moving to Paris and Sotret is not available there, so I am going to have to change brands.
	www.soulcysters.net /sotret-accutane-85865 (99 words)

	Pharmacist e-Link: News
		Pharmacies must register to continue dispensing isotretinoin products. The U.S. Food and Drug Administration (FDA) has approved iPLEDGE, an enhanced risk management program designed to minimize fetal exposure to isotretinoin. iPLEDGE will require mandatory registration of prescribers, patients, wholesalers, and pharmacies to further the public health goal to eliminate fetal exposure to isotretinoin.
		Starting December 30, 2005 unregistered and activated pharmacies will not be able to dispense Accutane® (isotretinoin), Amnesteem®, Claravis, or Sotret® to people with severe acne without enrolling in the FDA’s new iPLEDGE program through a physician who is enrolled.
		Pharmacies have two steps in preparing their pharmacies to dispense isotretinon prescriptions under iPledge "registration" and "activation" (After a pharmacy registers for iPledge on www.ipledgeprogram.com or calling 1-866-495-0654, the “Responsible Site Pharmacist” is sent a follow-up mailing, which contains instructions on how to activate their pharmacy.)
	www.pharmacistelink.com /news/story.asp?id=1960 (273 words)

	The Permanente Medical Group
		You have been prescribed or are considering Oral Isotretinoin Treatment.
		The medicine is also known as Accutane, Sotret and Amnesteem.
		Use of this medication will involve labwork and followup by your doctor and our nursing staff for at least a 20-week period.
	www.permanente.net /kaiser/pages/f45211.html (368 words)

	Isotretinoin use: Debate continues - Accutane emerges in low dosages, generics amid regulatory pressures, poor ...
		Some tout generics for cost savings, but in some ways, they can offer modifications of Accutane that are beneficial.
		For example, one new isotretinoin generic, Sotret (Ranbaxy Pharmaceuticals), offers a 30-mg dosage for patients weighing 130 pounds - the average weight of isotretinoin users, who tend to be 18- to 29-year-old females and teenage males in that weight class.
		Regulatory pressures There is pressure from some corners for the FDA to tighten regulatory use of isotretinoin.
	www.dermatologytimes.com /dermatologytimes/article/articleDetail.jsp?id=102173&pageID=2 (579 words)

	FDA Approves Isotretinoin Pregnancy Risk Management Program (Site not responding. Last check: 2007-10-03)
		Prescribers, wholesalers and pharmacies can begin registering with the enhanced program in the next few weeks, and patient enrollment will begin in November.
		Once the program is fully implemented in December 2005, Accutane, Amnesteem, Claravis and Sotret can only be prescribed by prescribers who are registered and activated with the iPLEDGE program.
		Isotretinoin can only be dispensed by a pharmacy registered and activated with iPLEDGE, and can only be dispensed to patients who are registered and meet all the requirements of iPLEDGE.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-12-2005/0004087545&EDATE= (781 words)

	Barr Pharmaceuticals, Inc. :: Barr Receives Approval for Isotretinoin Capsules USP, 30 mg
		Upon receiving approval for their Suitability Petition, Ranbaxy filed an ANDA for Isotretinoin Capsules USP, 30 mg in September 2002.
		Ranbaxy received FDA approval for its ANDA in June 2003 and currently markets the product under the tradename Sotret.
		Barr filed a Supplemental Abbreviated New Drug Application (sANDA) for the 30 mg strength of Isotretinoin Capsules USP with the FDA in June 2004 seeking approval to manufacture market this additional strength.
	sev.prnewswire.com /health-care-hospitals/20060512/NYF07912052006-1.html (867 words)

	GameKnot: chess player sotret (MAGDY BERAKA from CAIRO, Egypt)
		GameKnot: chess player sotret (MAGDY BERAKA from CAIRO, Egypt)
		Please log in for more options or to play chess online.
		GameKnot: play chess online, chess clubs, chess games database, free online chess games, bi-monthly chess tournaments, chess league, chess teams, chess puzzles and more.
	gameknot.com /stats.pl?sotret (44 words)

	Patient Registry To Reduce Accutane Use by Pregnant Women - iHealthBeat - Daily News Digest on Health Care Information ... (Site not responding. Last check: 2007-10-03)
		He said that he hopes iPledge "will be the program that ensures that we can get as close to the goal of the least pregnancy exposures as possible."
		iPledge replaces previous programs administered by Roche, which manufactures Accutane, and the manufacturers of three generic versions of the medication marketed as Amnesteem, Claravis and Sotret.
		American Academy of Dermatology spokesperson Jennifer Allyn said the group does not support iPledge.
	www.ihealthbeat.org /index.cfm?action=dspItem&itemid=117937 (428 words)

	amnesteem drug information, amnesteem side effects
		Save up to 80% on all prescriptions at 52,000 plus USA pharmacies by becoming a member.
		Isotretinoin Oral - (Accutane, Amnesteem, Claravis, Sotret) - Patient Handout from RxList
		Accutane Oral - (Accutane, Amnesteem, Claravis, Sotret) - Patient Handout from WebMD
	www.drugs.com /medicine/amnesteem (472 words)

	Sarah's Accutane Journal: Adventures with Lipbalm: August 2003 (Site not responding. Last check: 2007-10-03)
		I'm good with the Clean and Clear facial wash, which tingles like madness, and feels great.
		I've been on Amnesteen for 3 months, and then all of a sudden today they give me SOTRET!
		Okay, I guess I feel the need to bitch and complain, but seriously...do you know anything about this crap?
	www.hayllar.com /accutane/archives/001070.html (8865 words)

	Quick Reference: Accutane and Other Retinoids
		Accutane (isotretinoin) is a prescription medication used to treat a severe form of acne (nodular or cystic acne) that has not been helped by other treatments, including oral antibiotics.
		Other brands of isotretinoin (Amnesteem, Claravis, Sotret) also are available.
		Isotretinoin is a member of a family of drugs called retinoids, which are related to vitamin A. When taken during pregnancy, isotretinoin and other retinoids can cause miscarriage or very serious birth defects.
	www.marchofdimes.com /professionals/14332_1168.asp (2144 words)

	iPLEDGE implementation deadline looms (Site not responding. Last check: 2007-10-03)
		FDA received an update on the program’s implementation from the makers of the antiacne drug products available in the United States at the February 10 meeting of its Drug Safety and Risk Management Advisory Committee.
		iPLEDGE covers Roche’s Accutane, Genpharm’s Amnesteem, Mylan/Barr’s Claravis, and Ranbaxy’s Sotret.
		The primary purpose of the program is to ensure that women are not pregnant and do not become pregnant while taking the medication.
	www.pharmacist.com /articles/h_ts_1061.cfm (461 words)

	Adults fight acne - The Clarion-Ledger
		Antibiotic pills (haphazard use may lead to antibiotic resistance)
		Note: Accutane and Sotret can cause birth defects.
		Women who opt for this treatment must use foolproof birth control.
	www.clarionledger.com /apps/pbcs.dll/article?AID=/20060117/HEALTH/601170341 (721 words)

	FDA Patient Safety News: Show #45, November 2005 (Site not responding. Last check: 2007-10-03)
		Patients can begin registering and qualifying on December 30, 2005.
		FDA has developed stronger requirements to prevent fetal exposure to the drug Accutane (isotretinoin) along with its generic equivalents, such as Amnesteem, Sotret and Claravis.
		Isotretinoin is used to treat severe, recalcitrant, nodular acne, but it can cause serious birth defects if taken by pregnant women.
	www.accessdata.fda.gov /psn/printer.cfm?id=372 (384 words)

	ISOTRETINOIN - ORAL (Accutane, Amnesteem, Claravis, Sotret) side effects, medical uses, and drug interactions.
		ISOTRETINOIN - ORAL (Accutane, Amnesteem, Claravis, Sotret) side effects, medical uses, and drug interactions.
		MedicineNet Home > Medications A-Z List > ISOTRETINOIN-ORAL
		Please consult your healthcare provider before beginning any course of supplementation or treatment.
	www.medicinenet.com /isotretinoin-oral/article.htm (520 words)

Try your search on: Qwika (all wikis)